Hem › Hjärt-kärlsjukdom › Minnesota › Minneapolis
Kliniska studier för Hjärt-kärlsjukdom i Minneapolis, MN
15 studier för Hjärt-kärlsjukdom söker deltagare vid platser i och runt Minneapolis (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
ELEVATE-HFpEF Clinical Study
Rekryterar
- M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
Rekryterar
- Minneapolis Heart Institute, Minneapolis
Product Surveillance Registry
RekryterarObservationsstudie
- Minneapolis, Minneapolis
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Rekryterar
- Abbott Northwestern Hospital, Minneapolis
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Rekryterar
- Abbott Northwestern Hospital, Minneapolis
- University of Minnesota, Minneapolis
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
RekryterarObservationsstudie
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RekryterarFas 3
- Research Site, Minneapolis
- Research Site, Minneapolis
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RekryterarFas 3
- University of Minnesota, Minneapolis
- Methodist Hospital, Saint Louis Park · 5 mi bort
VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
Rekryterar
- Minneapolis Heart Institute Foundation, Minneapolis
The TRICURE EFS Study
Rekryterar
- Minneapolis Heart Institute Foundation, Minneapolis
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Rekryterar
- University of Minnesota, Minneapolis
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Rekryterar
- Minneapolis Heart Institute, Minneapolis
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
RekryterarFas 3
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure
RekryterarTidig fas 1
- University of Minnesota, Minneapolis
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Rekryterar
- Minneapolis Heart Institute Foundation, Minneapolis
Hjärt-kärlsjukdom-studier i andra städer
- Boston, MA37 studier
- New York City, NY33 studier
- Washington, DC28 studier
- Houston, TX24 studier
- Dallas, TX23 studier
- Atlanta, GA22 studier
- Cleveland, OH22 studier
- Chicago, IL21 studier
- Philadelphia, PA21 studier
- Pittsburgh, PA20 studier
- St. Louis, MO20 studier
- Nashville, TN18 studier
Andra studier i Minneapolis
- Icke-småcellig lungcancer27 studier
- Bröstcancer27 studier
- Äggstockscancer24 studier
- Prostatacancer23 studier
- Cancer (alla typer)22 studier
- Hjärtsvikt21 studier
- Akut myeloid leukemi20 studier
- Lungcancer20 studier
- Kolorektal cancer19 studier
- Endometriecancer18 studier
- Parkinsons sjukdom17 studier
- Kranskärlssjukdom13 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.